Smoking Cessation & Nicotine De-Addiction Product Market by Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers), Distribution (Drug Store, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024-2030

Smoking Cessation & Nicotine De-Addiction Product Market by Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers), Distribution (Drug Store, Hospital Pharmacies, Online Pharmacies) - Global Forecast 2024-2030


The Smoking Cessation & Nicotine De-Addiction Product Market size was estimated at USD 28.25 billion in 2023 and expected to reach USD 30.89 billion in 2024, at a CAGR 9.65% to reach USD 53.87 billion by 2030.

The smoking cessation and nicotine de-addiction market encompasses a variety of products and services designed to help individuals stop smoking and overcome nicotine addiction. Rising public awareness concerning the health hazards posed by smoking and nicotine addiction enhance the adoption of smoking cessation products. Stringent regulations and policies aiming to curb smoking rates contribute to the market growth. Ongoing innovations in product offerings, such as e-cigarettes and app-based support for smoking cessation. However, stringent regulations and the potential banning of certain nicotine-containing products can hamper market growth. The high propensity for relapse among quitters poses a persistent challenge to the efficacy of cessation products. Moreover, developing personalized cessation plans using big data analytics to improve success rates. Wearable devices that monitor physiological parameters to offer real-time support and feedback, enhancing use of smoking cessation and nicotine de-addiction products.

Regional Insights

The United States and Canada represent significant markets for smoking cessation products in the Americas. The Americas region is characterized by high consumer awareness and willingness to adopt smoking cessation aids, supported by healthcare policies and community support programs. The EMEA region presents a mixed picture, with EU countries leading in smoking cessation initiatives, while the Middle East and Africa face challenges due to varying regulatory environments and smoking culture. Strict advertising restrictions and smoke-free laws drive the demand for smoking cessation products in European countries. The Asia Pacific region, comprising significant markets such as China, Japan, and India, showcases diverse consumer behavior towards smoking cessation. Robust governmental anti-smoking policies combined with a growing awareness of smoking hazards contribute to the escalating demand for nicotine de-addiction products in the APAC region.

Market Insights
  • Market Dynamics

    The market dynamics represent an ever-changing landscape of the Smoking Cessation & Nicotine De-Addiction Product Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
    • Market Drivers
      • Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
      • Expanding Market Penetration of De-Addiction Products Globally
      • Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
      • Market Restraints
        • Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
        • Market Opportunities
          • Increasing Approvals and Development of New Nicotine Replacement Products
          • Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
          • Market Challenges
            • Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco
            • Market Segmentation Analysis
              • Product: Rising adoption of E-cigarettes for smoking cessation
              • Distribution: Customer inclination towards online pharmacies for convenience and discretion
              • Market Disruption Analysis
              • Porter’s Five Forces Analysis
              • Value Chain & Critical Path Analysis
              • Pricing Analysis
              • Technology Analysis
              • Patent Analysis
              • Trade Analysis
              • Regulatory Framework Analysis
              FPNV Positioning Matrix

              The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Smoking Cessation & Nicotine De-Addiction Product Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

              Market Share Analysis

              The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Smoking Cessation & Nicotine De-Addiction Product Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

              Recent Developments
              • BC Cancer Launches Nicotine Replacement Therapy Pilot Program in Prince George

                BC Cancer has launched an innovative Nicotine Replacement Therapy (NRT) pilot program at its Prince George center, aimed at assisting patients undergoing cancer treatment in overcoming the challenge of smoking cessation. Recognizing the particular difficulties faced by individuals in remote and rural communities in accessing pharmacies, this program prominently features the provision of NRT options such as patches and gum directly to patients.

                Imperial Tobacco Canada Is Excited To Launch A Smoking Cessation Product

                Imperial Tobacco Canada announced that Health Canada has approved ZONNIC, a nicotine pouch developed by Nicoventures Trading Limited, a subsidiary of ITCAN's parent company, British American Tobacco (BAT), for sale in Canada. This marks a premier event as ZONNIC becomes the first nicotine pouch in Canada to receive Health Canada's endorsement, positioning it as a novel cessation aid for adult smokers. As the exclusive distributor of ZONNIC in Canada, ITCAN enhances its commitment to minimizing the health impacts associated with smoking.

                NCDHHS Launches New QuitlineNC Services to Make Stopping Tobacco Use and Vaping More Accessible

                In an effort to combat the persistently high rates of tobacco use in North Carolina, the Department of Health and Human Services has unveiled enhancements to QuitlineNC, a premier resource for individuals seeking to overcome nicotine addiction, including those who smoke, vape, or use e-cigarettes. With a suite of expanded services, QuitlineNC now offers access to expert Quit Coaches via live chat, text messaging, group video sessions, and a customizable dashboard for tracking progress.
              Strategy Analysis & Recommendation

              The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Smoking Cessation & Nicotine De-Addiction Product Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

              Key Company Profiles

              The report delves into recent significant developments in the Smoking Cessation & Nicotine De-Addiction Product Market, highlighting leading vendors and their innovative profiles. These include 22nd Century Group, Inc., Alkalon A/S, Axsome Therapeutics, Inc., British American Tobacco PLC, Cipla Ltd., Ditch Labs, Dr. Reddy’s Laboratories Limited, Enorama Pharma AB, GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Imperial Tobacco Company of India Limited, Itaconix, Japan Tobacco Inc., Johnson & Johnson, JUUL Labs, Inc., Novartis International AG, Perrigo Company PLC, Pfizer Inc., Philip Morris International Inc., Pierre Fabre S.A., Rusan Pharma Ltd., Samyang Holdings Corporation, Sparsha Pharma International Pvt. Ltd., and Strides Pharma Science Limited.

              Market Segmentation & Coverage

              This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product Market to forecast the revenues and analyze trends in each of the following sub-markets:
              • Product
                • Drug Therapy
                  • Chantix (Varenicline)
                  • Zyban (Bupropion)
                  • E-Cigarettes
                  • Nicotine Inhalers
                  • Nicotine Replacement Therapies
                    • Nicotine Gums
                    • Nicotine Lozenges
                    • Nicotine Sprays
                    • Nicotine Transdermal Patches
                    • Nicotine Sublingual Tablets
                    • Distribution
                      • Drug Store
                      • Hospital Pharmacies
                      • Online Pharmacies
                      • Retail Pharmacies
                      • Region
                        • Americas
                          • Argentina
                          • Brazil
                          • Canada
                          • Mexico
                          • United States
                            • California
                            • Florida
                            • Illinois
                            • New York
                            • Ohio
                            • Pennsylvania
                            • Texas
                            • Asia-Pacific
                              • Australia
                              • China
                              • India
                              • Indonesia
                              • Japan
                              • Malaysia
                              • Philippines
                              • Singapore
                              • South Korea
                              • Taiwan
                              • Thailand
                              • Vietnam
                              • Europe, Middle East & Africa
                                • Denmark
                                • Egypt
                                • Finland
                                • France
                                • Germany
                                • Israel
                                • Italy
                                • Netherlands
                                • Nigeria
                                • Norway
                                • Poland
                                • Qatar
                                • Russia
                                • Saudi Arabia
                                • South Africa
                                • Spain
                                • Sweden
                                • Switzerland
                                • Turkey
                                • United Arab Emirates
                                • United Kingdom


                                Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
5.1.1.2. Expanding Market Penetration of De-Addiction Products Globally
5.1.1.3. Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness of the Health Impact due to Smoking
5.1.2. Restraints
5.1.2.1. Product Recalls by the Manufacturer and Companies owing to increasing Technical Faults and Stringent Approval Process
5.1.3. Opportunities
5.1.3.1. Increasing Approvals and Development of New Nicotine Replacement Products
5.1.3.2. Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
5.1.4. Challenges
5.1.4.1. Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rising of Alternatives to Tobacco
5.2. Market Segmentation Analysis
5.2.1. Product: Rising adoption of E-cigarettes for smoking cessation
5.2.2. Distribution: Customer inclination towards online pharmacies for convenience and discretion
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product
6.1. Introduction
6.2. Drug Therapy
6.3. E-Cigarettes
6.4. Nicotine Inhalers
6.5. Nicotine Replacement Therapies
6.6. Nicotine Sublingual Tablets
7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution
7.1. Introduction
7.2. Drug Store
7.3. Hospital Pharmacies
7.4. Online Pharmacies
7.5. Retail Pharmacies
8. Americas Smoking Cessation & Nicotine De-Addiction Product Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. BC Cancer Launches Nicotine Replacement Therapy Pilot Program in Prince George
11.3.2. Imperial Tobacco Canada Is Excited To Launch A Smoking Cessation Product
11.3.3. NCDHHS Launches New QuitlineNC Services to Make Stopping Tobacco Use and Vaping More Accessible
12. Competitive Portfolio
12.1. Key Company Profiles
12.2. Key Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings